Development of a new catheter prototype for laser thrombolysis under guidance of optical coherence tomography (OCT): validation of feasibility and efficacy in a preclinical model
In this feasibility study, a novel catheter prototype for laser thrombolysis under the guidance of optical coherence tomography (OCT) was designed and evaluated in a preclinical model. Human arteries and veins were integrated into a physiological flow model and occluded with thrombi made from the Chandler Loop. There were four experimental groups: placebo, 20 mg alteplase, laser, 20 mg alteplase + laser. The extent of thrombolysis was analyzed by weighing, OCT imaging and relative thrombus size. In the alteplase group, thrombus size decreased to 0.250 ± 0.036 g (p < 0.0001) and 14.495 ± 0.526 mm2 (p < 0.0001) at 60 min. The relative thrombus size decreased to 73.6 ± 4.1% at 60 min (p < 0.0001). In the laser group, thrombus size decreased significantly to 0.145 ± 0.028 g (p < 0.0001) and 11.559 ± 1.034 mm2 (p < 0.0001). In the alteplase + laser group, thrombus size decreased significantly (0.051 ± 0.026 g; p < 0.0001; 9.622 ± 0.582 mm2; p < 0.0001; 47.4 ± 6.1%; p < 0.0001) in contrast to sole alteplase and laser application. The reproducibility and accuracy of the OCT imaging was high (SD <10%). Histological examination showed no relevant destruction of the vascular layers after laser ablation (arteries: 745.8 ± 5.5 μm; p = 0.69; veins: 448.3 ± 4.5 μm; p = 0.27). Thus, laser ablation and OCT imaging are feasible with the novel catheter and thrombolysis combining alteplase with laser irradiation appears highly efficient.
KeywordsThrombosis Thrombolysis Laser OCT Endovascular therapy
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Vandvik PO, Lincoff AM, Gore JM, Gutterman D D, Sonnenberg FA, Alonso-Coello P, Akl EA, Lansberg MG, Guyatt GH, Spencer FA (2012). Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians evidence-based clinical practice guidelines. CHEST J, 141(2_suppl), e637S–e668SGoogle Scholar
- 2.Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Lohr JM, McLafferty RB, Murad MH, Padberg F, Pappas P, Raffetto JD, Wakefield TW (2012) Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J vasc surg 55(5):1449–1462CrossRefPubMedGoogle Scholar
- 6.Soest CG, Goderie T, Regar E, Koljenovic S, van Leenders GL, Gonzalo N, van Noorden S, Okamura T, Bourma BE, Tearny GJ, Oosterhuis JW, Serruys PW, van der Steen AF (2010) Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging. J Biomed Opt 15(1):011105CrossRefPubMedGoogle Scholar
- 11.Van der Steenhoven TJ, Bosman PF, Tersteeg C, Jacobs MJ, Moll FL, de Groot PG, Heyligers JM (2012) Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model. Eur J Vasc Endovasc Surg 43(6):675–680CrossRefPubMedGoogle Scholar
- 14.Tsetis DK, Katsamouris AN, Giannoukas AD, Hatzidakis AA, Kostas T, Chamalakis K, Ioannou C, Gourtsoyiannis NC (2003) Potential benefits from heating the high-dose rtPA boluses used in catheter-directed thrombolysis for acute/subacute lower limb ischemia. J Endovasc Ther 10(4):739–744PubMedGoogle Scholar
- 22.Wilkoff BL, Byrd CL, Love CJ, Hayes DL, Sellers TD, Schaerf R, Parsonnet V, Epstein LM, Sorrentino RA, Reiser C (1999) Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol 33(6):1671–1676CrossRefPubMedGoogle Scholar
- 25.Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon-Hernandez PJ, Stark MA, Walker C (2015). Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC 8(1):92–101.PubMedGoogle Scholar